WALDENSTROM MACROGLOBULINAEMIA
Clinical trials for WALDENSTROM MACROGLOBULINAEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM MACROGLOBULINAEMIA trials appear
Sign up with your email to follow new studies for WALDENSTROM MACROGLOBULINAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR T-Cell therapy targets tough lymphoma cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called SynKIR-310 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment uses a patient's own immune cells, modified to recognize and attack cancer cells. The main…
Matched conditions: WALDENSTROM MACROGLOBULINAEMIA
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New study aims to catch nerve damage early in rare blood cancer
Knowledge-focused Recruiting nowThis study looks at why people with Waldenström's macroglobulinemia (a rare blood cancer) often develop nerve damage, causing pain, numbness, and trouble moving. Researchers will screen 90 patients to find how common this nerve damage is and what causes it. The goal is to speed u…
Matched conditions: WALDENSTROM MACROGLOBULINAEMIA
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 26, 2026 05:49 UTC